Menu

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

Article |

aerocasterc4 10d ago
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

The deals are part of Eli Lilly's effort to expand into infectious disease research and development. Its acquiring biotech firms Curevo, LimmaTech Biologics...

Comments (0)

Newest

No comments yet.